Alcon, Staar Surgical announce expiration of HSR waiting period

Alcon (ALC) and STAAR Surgical Company (STAA) announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, HSR, in connection with Alcon’s acquisition of STAAR, expired at 11:59 p.m. ET on September 29, 2025. As previously announced, under the terms of the agreement, Alcon will purchase all outstanding shares of STAAR common stock for $28 per share in cash, which represents approximately a 59% premium to STAAR’s 90-day volume weighted average price and a 51% premium to the closing price of STAAR common stock on August 4, 2025. The transaction represents a total equity value of approximately $1.5 billion.